Learning Objectives:

  1. Understand progress made in providing genetic cancer risk assessment services in oncology
  2. Describe emerging science of cancer interception
  3. Understand the rationale for integrating ethnic specific polygenic risk score for cancer risk assessment
Session date: 
10/08/2018 - 12:00pm to 1:00pm CDT
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Clinical Cancer Genetics Team